These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 7550349

  • 1. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.
    Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC.
    Nat Genet; 1995 Oct; 11(2):198-200. PubMed ID: 7550349
    [Abstract] [Full Text] [Related]

  • 2. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
    Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, Norton L, Borgen P, Jhanwar S, Goldgar D, Ostrer H, Offit K.
    Nat Genet; 1996 Oct; 14(2):188-90. PubMed ID: 8841192
    [Abstract] [Full Text] [Related]

  • 3. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
    Roa BB, Boyd AA, Volcik K, Richards CS.
    Nat Genet; 1996 Oct; 14(2):185-7. PubMed ID: 8841191
    [Abstract] [Full Text] [Related]

  • 4. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.
    Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, Hampel H, Borgen P, Brown K, Skolnick M, Shattuck-Eidens D, Jhanwar S, Goldgar D, Offit K.
    Nat Genet; 1996 May; 13(1):126-8. PubMed ID: 8673092
    [Abstract] [Full Text] [Related]

  • 5. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.
    Shiri-Sverdlov R, Oefner P, Green L, Baruch RG, Wagner T, Kruglikova A, Haitchick S, Hofstra RM, Papa MZ, Mulder I, Rizel S, Bar Sade RB, Dagan E, Abdeen Z, Goldman B, Friedman E.
    Hum Mutat; 2000 Dec; 16(6):491-501. PubMed ID: 11102978
    [Abstract] [Full Text] [Related]

  • 6. Frequency of the BRCA1 185delAG mutation among Jewish women with ovarian cancer and matched population controls.
    Muto MG, Cramer DW, Tangir J, Berkowitz R, Mok S.
    Cancer Res; 1996 Mar 15; 56(6):1250-2. PubMed ID: 8640808
    [Abstract] [Full Text] [Related]

  • 7. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.
    Berman DB, Costalas J, Schultz DC, Grana G, Daly M, Godwin AK.
    Cancer Res; 1996 Aug 01; 56(15):3409-14. PubMed ID: 8758903
    [Abstract] [Full Text] [Related]

  • 8. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K.
    Clin Cancer Res; 2002 Dec 01; 8(12):3776-81. PubMed ID: 12473589
    [Abstract] [Full Text] [Related]

  • 9. The I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds.
    Petrukhin L, Dangel J, Vanderveer L, Costalas J, Bellacosa A, Grana G, Daly M, Godwin AK.
    Cancer Res; 1997 Dec 15; 57(24):5480-4. PubMed ID: 9407954
    [Abstract] [Full Text] [Related]

  • 10. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.
    Phelan CM, Kwan E, Jack E, Li S, Morgan C, Aubé J, Hanna D, Narod SA.
    Hum Mutat; 2002 Nov 15; 20(5):352-7. PubMed ID: 12402332
    [Abstract] [Full Text] [Related]

  • 11. Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer.
    Foulkes WD, Wong N, Brunet JS, Bégin LR, Zhang JC, Martinez JJ, Rozen F, Tonin PN, Narod SA, Karp SE, Pollak MN.
    Clin Cancer Res; 1997 Dec 15; 3(12 Pt 1):2465-9. PubMed ID: 9815648
    [Abstract] [Full Text] [Related]

  • 12. High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history.
    Beller U, Halle D, Catane R, Kaufman B, Hornreich G, Levy-Lahad E.
    Gynecol Oncol; 1997 Nov 15; 67(2):123-6. PubMed ID: 9367693
    [Abstract] [Full Text] [Related]

  • 13. Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients.
    Tobias DH, Eng C, McCurdy LD, Kalir T, Mandelli J, Dottino PR, Cohen CJ.
    Gynecol Oncol; 2000 Aug 15; 78(2):148-51. PubMed ID: 10926794
    [Abstract] [Full Text] [Related]

  • 14. Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer.
    Schorge JO, Mahoney NM, Miller DS, Coleman RL, Muller CY, Euhus DM, Tomlinson GE.
    Gynecol Oncol; 2001 Nov 15; 83(2):383-7. PubMed ID: 11606101
    [Abstract] [Full Text] [Related]

  • 15. A common BRCA1 mutation in the Ashkenazim.
    Goldgar DE, Reilly PR.
    Nat Genet; 1995 Oct 15; 11(2):113-4. PubMed ID: 7550331
    [No Abstract] [Full Text] [Related]

  • 16. High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer.
    Grzybowska E, Zientek H, Jasinska A, Rusin M, Kozlowski P, Sobczak K, Sikorska A, Kwiatkowska E, Gorniak L, Kalinowska E, Utracka-Hutka B, Wloch J, Chmielik E, Krzyzosiak WJ.
    Hum Mutat; 2000 Dec 15; 16(6):482-90. PubMed ID: 11102977
    [Abstract] [Full Text] [Related]

  • 17. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM, Offit K, Foulkes W, Robson ME, Wacholder S, Eng CM, Karp SE, Begg CB.
    Cancer Epidemiol Biomarkers Prev; 2001 May 15; 10(5):467-73. PubMed ID: 11352856
    [Abstract] [Full Text] [Related]

  • 18. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.
    FitzGerald MG, MacDonald DJ, Krainer M, Hoover I, O'Neil E, Unsal H, Silva-Arrieto S, Finkelstein DM, Beer-Romero P, Englert C, Sgroi DC, Smith BL, Younger JW, Garber JE, Duda RB, Mayzel KA, Isselbacher KJ, Friend SH, Haber DA.
    N Engl J Med; 1996 Jan 18; 334(3):143-9. PubMed ID: 8531968
    [Abstract] [Full Text] [Related]

  • 19. Association of the I1307K APC mutation with hereditary and sporadic breast/ovarian cancer: more questions than answers.
    Gershoni-Baruch R, Patael Y, Dagan, Figer A, Kasinetz L, Kadouri E, Bruchim Bar Sade R, Friedman E.
    Br J Cancer; 2000 Jul 18; 83(2):153-5. PubMed ID: 10901363
    [Abstract] [Full Text] [Related]

  • 20. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
    Cierniková S, Tomka M, Kovác M, Stevurková V, Zajac V.
    Neoplasma; 2006 Jul 18; 53(2):97-102. PubMed ID: 16575464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.